CORRECTED-BRIEF-Transcept Pharma, Purdue Pharma file action against Novel

Tue Sep 11, 2012 5:19pm EDT

(Corrects headline to say Transcept and Purdue filed action alleging patent infringement by Novel Labs. They received a Paragraph IV notice letter from Novel on July 31, which was reported earlier)

Sept 11 (Reuters) - Sept 11 (Reuters) - Transcept Pharmaceuticals Inc : * Transcept pharmaceuticals Inc joined Purdue Pharmaceutical products, Purdue Pharma L.P. in filing action against Novel - SEC filing * Action alleging infringement of the '628 patent' and seeking injunctive and other relief against Novel. * Commencement of the action automatically stays FDA approval of the Novel ANDA until January 2015 (Reporting by Balaji Sridharan in Bangalore)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.